Related Experiment Video
Updated: Dec 24, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li1,2, Manman Geng1,2, Yizhao Peng1,2
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19. This review covers SARS-CoV-2 features, pathogenesis, diagnosis, and treatment, drawing insights from SARS-CoV and MERS-CoV.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is a viral pneumonia caused by SARS-CoV-2.
- SARS-CoV-2 is the third highly pathogenic coronavirus to infect humans this century, following SARS-CoV and MERS-CoV.
- Understanding prior coronavirus outbreaks is crucial for addressing the current pandemic.
Purpose of the Study:
- To provide an overview of SARS-CoV-2 general features.
- To discuss the molecular immune pathogenesis of COVID-19.
- To explore current diagnostic and treatment strategies for COVID-19, informed by SARS-CoV and MERS-CoV.
Main Methods:
- Minireview of existing scientific literature.
- Comparative analysis of SARS-CoV-2 with SARS-CoV and MERS-CoV.
- Synthesis of current knowledge on viral pathogenesis, diagnosis, and treatment.
Main Results:
- General characteristics of SARS-CoV-2 are outlined.
- Insights into the molecular immune pathogenesis of COVID-19 are presented.
- Current diagnostic and therapeutic approaches are reviewed, highlighting parallels with SARS and MERS.
Conclusions:
- Knowledge from SARS-CoV and MERS-CoV infections offers valuable insights into SARS-CoV-2.
- Understanding pathogenesis, diagnosis, and treatment can identify potential therapeutic targets.
- This review aims to contribute novel perspectives for combating SARS-CoV-2 infection.
Abstract:
Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Myocarditis II: Clinical Features and Diagnostic Tests

